Select Page

Novelos Therapeutics prices public offering

Novelos Therapeutics Inc., a Madison company developing drugs to diagnose and treat cancer, said Friday it is pricing a public offering of 5,420,800 units at $1 each. (JOURNAL SENTINEL, 6/11)
To access this content, you must purchase a Premium membership, or log in if you are a member.

STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.

Subscribe here for a FREE 14 day trial of our daily news roundup.

You have Successfully Subscribed!

Pin It on Pinterest